BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32034715)

  • 21. STAT proteins as novel targets for cancer drug discovery.
    Turkson J
    Expert Opin Ther Targets; 2004 Oct; 8(5):409-22. PubMed ID: 15469392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
    Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases.
    Kreis S; Munz GA; Haan S; Heinrich PC; Behrmann I
    Mol Cancer Res; 2007 Dec; 5(12):1331-41. PubMed ID: 18171991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ivermectin accelerates autophagic death of glioma cells by inhibiting glycolysis through blocking GLUT4 mediated JAK/STAT signaling pathway activation.
    Feng Y; Wang J; Cai B; Bai X; Zhu Y
    Environ Toxicol; 2022 Apr; 37(4):754-764. PubMed ID: 34904774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mast cell homeostasis and the JAK-STAT pathway.
    Morales JK; Falanga YT; Depcrynski A; Fernando J; Ryan JJ
    Genes Immun; 2010 Dec; 11(8):599-608. PubMed ID: 20535135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SFK-STAT pathway: an alternative and important way to malignancies.
    Hayakawa F; Naoe T
    Ann N Y Acad Sci; 2006 Nov; 1086():213-22. PubMed ID: 17185518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of STAT signaling in inflammation and tumorigenesis.
    Adach A; Ellert-Miklaszewska A; Kaminska B
    Methods Mol Biol; 2009; 512():265-78. PubMed ID: 19347282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STAT proteins: a kaleidoscope of canonical and non-canonical functions in immunity and cancer.
    Awasthi N; Liongue C; Ward AC
    J Hematol Oncol; 2021 Nov; 14(1):198. PubMed ID: 34809691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell type-specific signaling in response to interferon-gamma.
    van Boxel-Dezaire AH; Stark GR
    Curr Top Microbiol Immunol; 2007; 316():119-54. PubMed ID: 17969446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Model-driven experimental analysis of the function of SHP-2 in IL-6-induced Jak/STAT signaling.
    Dittrich A; Quaiser T; Khouri C; Görtz D; Mönnigmann M; Schaper F
    Mol Biosyst; 2012 Aug; 8(8):2119-34. PubMed ID: 22711165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
    Himpe E; Kooijman R
    Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting signal transducer and activator of transcription signaling pathway in leukemias.
    Benekli M; Baumann H; Wetzler M
    J Clin Oncol; 2009 Sep; 27(26):4422-32. PubMed ID: 19667270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled.
    Reddy EP; Korapati A; Chaturvedi P; Rane S
    Oncogene; 2000 May; 19(21):2532-47. PubMed ID: 10851052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JAK-STAT signaling in cancer: From cytokines to non-coding genome.
    Pencik J; Pham HT; Schmoellerl J; Javaheri T; Schlederer M; Culig Z; Merkel O; Moriggl R; Grebien F; Kenner L
    Cytokine; 2016 Nov; 87():26-36. PubMed ID: 27349799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Canonical JAK-STAT signaling is pivotal for long-term depression at adult hippocampal temporoammonic-CA1 synapses.
    McGregor G; Irving AJ; Harvey J
    FASEB J; 2017 Aug; 31(8):3449-3466. PubMed ID: 28461339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type II cGMP‑dependent protein kinase inhibits EGF‑induced JAK/STAT signaling in gastric cancer cells.
    Wu M; Wu Y; Lan T; Jiang L; Qian H; Chen Y
    Mol Med Rep; 2016 Aug; 14(2):1849-56. PubMed ID: 27357186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Research Advances of JAK/STAT Signaling Pathway in Lung Cancer].
    Yang X; Tang Z; Zhang P; Zhang L
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):45-51. PubMed ID: 30674393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The molecular details of cytokine signaling via the JAK/STAT pathway.
    Morris R; Kershaw NJ; Babon JJ
    Protein Sci; 2018 Dec; 27(12):1984-2009. PubMed ID: 30267440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.